CLOCK and cancer: The differential expression analysis of the core clock genes across cancers was performed with DESeq2 software, and the significant results (adjusted P < 0.05) are shown in Figure 2A. It was clear that the expression levels of core clock genes were significantly downregulated in almost all cancers.